Excellent post, PeeWee333. The research has certainly now been done.
And, just to clarify with regard to Ropren "approval," here are the facts (quoted from the Solagran announcement):
"The next step for Solagran is to obtain a manufacturing licence which will apply throughout
Russia. This process involves obtaining approval firstly at local level, followed by state and
finally federal level approval. It is a procedure that usually takes 2-3 months."
Usually. That's the key word. Ropren "approval" took about a year longer than expected, so further delays cannot be discounted. However, I see that this uncertainty is now beginning to be factored into the share price.
- Forums
- ASX - By Stock
- SLA
- wait before topping up
wait before topping up, page-18
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)